Candesartan Cilexetil-hydrochlorothiazide
Pricing Report NDC 49884-662-09

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Candesartan Cilexetil-hydrochlorothiazide (NDC 49884-662-09) is $3.60283 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Dec 21, 2016.

As a provided by Par Pharmaceutical Inc., this medication is distributed in a 90 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$3.60283
Per EA

Effective Date
Dec 21, 2016
Billable Units
90 EA
Estimated Package Price
$324.25
Data Status
As of Jan 18, 2017
C/I - Chain or Independent Pharmacy
Package NDC
Description
90 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $1.55133 to $3.60283 per EA. Over this 3 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.5513 - $3.6028
Market Volatility
132.24% Variance
Latest Trend
13.58%
Date Unit Price Unit Source Method Rate
Dec 21, 2016 $3.60283 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 21, 2016 $3.60283 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Oct 19, 2016 $3.17199 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 19, 2016 $3.17199 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Aug 17, 2016 $3.24491 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 17, 2016 $3.24491 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jul 20, 2016 $3.23756 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 18, 2016 $2.02826 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 18, 2016 $2.02826 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Mar 23, 2016 $2.39773 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 23, 2016 $2.39773 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Oct 21, 2015 $1.62993 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 21, 2015 $1.62993 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Aug 19, 2015 $2.07721 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 19, 2015 $2.07721 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jun 17, 2015 $2.36896 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 17, 2015 $2.36896 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
May 20, 2015 $2.76662 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2014 $2.11339 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2014 $2.11339 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Oct 22, 2014 $1.96321 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2014 $2.16340 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $1.83597 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2014 $2.12876 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2014 $1.79328 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2014 $1.76189 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2014 $1.92821 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2014 $1.76547 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2014 $2.14815 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2013 $2.22269 EAC/I - Chain or Independent PharmacyCode 3, 6G - Generic
Dec 18, 2013 $2.22269 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Nov 21, 2013 $1.55133 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026